Effects of danazol on incidence of progesterone and oestrogen receptors in benign breast disease

C Panahy, J R Puddefoot, E Anderson, Élizabeth Anderson, G. P. Vinson, C. L. Berry, M J Turner, Michael J. Turner, C. L. Brown, A W Goode
British medical journal (Clinical research ed.) · 1987 · vol. 295(6596) , pp. 464–466 · doi:10.1136/bmj.295.6596.464 · PMID:3117172 · PMC1247328 · W2013175168
Non-randomised trial OA: bronze CC0 ⤵ 3 in-corpus citations
📄 Open PDF View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Danazol treatment of benign breast disease increased progesterone receptors long-term in responders and transiently increased estrogen receptors, with clinical response maintained in a subset of patients.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Results from a continuing clinical trial in benign breast disease indicate that danazol may induce progesterone receptors and that this effect persists after treatment. In women given danazol the number of biopsy specimens that were positive for progesterone receptors rose from 14 out of 31 before treatment to 23 out of 30 at the end of six months' treatment and remained raised at 21 out of 31 six months later. The number of biopsy specimens that were positive for oestrogen receptors rose transiently from eight out of 31 to 12 out of 30 and then fell to six out of 31. A satisfactory clinical response was achieved in 26 of the 31 patients but was maintained in only 11 six months or more after the end of treatment. It was only in this group that a significant and long-standing increase in progesterone receptors was observed. These findings suggest that in some women with benign breast disease who have been treated with danazol changes occur that may have long term benefit.

My notes (saved in your browser only)

MeSH descriptors

Breast Diseases Danazol Pregnadienes Receptors, Estrogen Receptors, Progesterone Adult Breast Breast Breast Diseases Breast Diseases Clinical Trials as Topic Danazol Female Humans Pain Pain Pregnadienes Receptors, Estrogen Receptors, Estrogen Receptors, Progesterone

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (26)

Cited by (3)

Source provenance

openalex
last seen: 2026-05-10T10:48:52.009453+00:00
pubmed
last seen: 2026-10-08T21:24:43.058907+00:00
License: CC0 · commercial use OK